Global News

Clinipace, Medfiles partner

Monday, August 5, 2013 11:55 AM

Global CRO Clinipace Worldwide has partnered with Finland-based CRO Medfiles, which specializes in pharmaceutical development and analytical services, clinical trial support, health economics and regulatory affairs.

More... »

The CenterWatch Monthly, August 2013

Friday, August 2, 2013 10:36 AM

Will end-to-end outsourcing take hold?

More... »

Moderna Therapeutics names Joseph Bolen president of R&D

Thursday, August 1, 2013 12:27 PM

Moderna Therapeutics, developing messenger RNA therapeutics, a new treatment modality to enable the in vivo production of therapeutic proteins, has hired Joseph Bolen, Ph.D., as its president of R&D.

More... »

Bionomics, Merck ink $172 million research collaboration

Thursday, August 1, 2013 11:31 AM

Bionomics has announced an agreement with Merck to discover and develop novel small molecule candidates for the treatment of chronic pain, including neuropathic pain. The initial period of the research program will be two years. 

More... »

La Jolla Institute, Kyowa Hakko Kirin extend research collaboration

Thursday, August 1, 2013 11:00 AM

La Jolla Institute for Allergy and Immunology and Kyowa Hakko Kirin California (KKC), a global specialty pharmaceutical company, have signed a new partnership agreement through the end of 2018.

More... »

Certara launches Cardiac Safety Simulator

Thursday, August 1, 2013 09:30 AM

St. Louis-based Certara, a provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, has launched its Cardiac Safety Simulator (CSS), based on an in-silico model of human ventricular heart cells.

More... »

RPS, PRA to merge under KKR ownership

Wednesday, July 31, 2013 01:51 PM

Global investment firm KKR has signed a definitive agreement to acquire ReSearch Pharmaceutical Services (RPS), a global CRO, from Warburg Pincus.

More... »

Quanterix launches Simoa Single Molecule Array technology

Wednesday, July 31, 2013 11:53 AM

Quanterix, a company focused on high definition diagnostics, has launched its Single Molecule Array (Simoa) technology, making it commercially available for the first time on a fully automated platform for research use only. Simoa enables life science researchers to explore biomarkers and pathways with greater sensitivity and precision, allowing the development of new diagnostic tests and improved treatment of diseases in oncology, neurology and cardiology.

More... »

AstraZeneca, FibroGen collaborate to develop and commercialize FG-4592

Wednesday, July 31, 2013 11:51 AM

AstraZeneca and biotechnology company FibroGen have entered into a collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), which also may be extended to other anemia indications.

More... »

StemCells launches Alzheimer's program supported by CIRM

Wednesday, July 31, 2013 11:47 AM

StemCells has launched its Alzheimer's disease program, supported by the California Institute for Regenerative Medicine (CIRM). The goal is to file, within four years, an IND application with the FDA to evaluate the company's proprietary HuCNS-SC product candidate (purified human neural stem cells) as a potential therapeutic in the treatment of Alzheimer's disease.

More... »